246 related articles for article (PubMed ID: 2614012)
1. More on smoking habits and Graves' ophthalmopathy.
Bartalena L; Martino E; Marcocci C; Bogazzi F; Panicucci M; Velluzzi F; Loviselli A; Pinchera A
J Endocrinol Invest; 1989 Nov; 12(10):733-7. PubMed ID: 2614012
[TBL] [Abstract][Full Text] [Related]
2. Influence of smoking on Graves' disease with or without ophthalmopathy and nontoxic nodular goiter in Taiwan.
Chen YL; Chang TC; Chen CJ
J Formos Med Assoc; 1994 Jan; 93(1):40-4. PubMed ID: 7915579
[TBL] [Abstract][Full Text] [Related]
3. Graves' ophthalmopathy and tobacco smoking.
Tallstedt L; Lundell G; Taube A
Acta Endocrinol (Copenh); 1993 Aug; 129(2):147-50. PubMed ID: 8103953
[TBL] [Abstract][Full Text] [Related]
4. Smoking and thyroid disorders--a meta-analysis.
Vestergaard P
Eur J Endocrinol; 2002 Feb; 146(2):153-61. PubMed ID: 11834423
[TBL] [Abstract][Full Text] [Related]
5. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
6. Smoking and risk of Graves' disease.
Prummel MF; Wiersinga WM
JAMA; 1993 Jan; 269(4):479-82. PubMed ID: 8419666
[TBL] [Abstract][Full Text] [Related]
7. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype.
Manji N; Carr-Smith JD; Boelaert K; Allahabadia A; Armitage M; Chatterjee VK; Lazarus JH; Pearce SH; Vaidya B; Gough SC; Franklyn JA
J Clin Endocrinol Metab; 2006 Dec; 91(12):4873-80. PubMed ID: 16968788
[TBL] [Abstract][Full Text] [Related]
8. Evidence of extraocular muscle restriction in autoimmune thyroid disease.
Gamblin GT; Galentine P; Chernow B; Smallridge RC; Eil C
J Clin Endocrinol Metab; 1985 Jul; 61(1):167-71. PubMed ID: 3838999
[TBL] [Abstract][Full Text] [Related]
9. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis.
Wall JR; Bernard N; Boucher A; Salvi M; Zhang ZG; Kennerdell J; Tyutyunikov A; Genovese C
Clin Immunol Immunopathol; 1993 Jul; 68(1):1-8. PubMed ID: 8513588
[TBL] [Abstract][Full Text] [Related]
12. [Soluble forms of adhesion molecules sELAM-1 and sICAM-1 in Graves disease and toxic nodular goiter].
Modelska-Ziółkiewicz A; Gembicki M; Sowiński J
Pol Arch Med Wewn; 2003 May; 109(5):463-8. PubMed ID: 14768174
[TBL] [Abstract][Full Text] [Related]
13. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
14. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
[TBL] [Abstract][Full Text] [Related]
15. Increased serum neopterin levels in patients with Graves' disease.
Wagner R; Hayatghebi S; Rosenkranz M; Reinwein D
Exp Clin Endocrinol; 1993; 101(4):249-54. PubMed ID: 8307114
[TBL] [Abstract][Full Text] [Related]
16. Graves' disease associated with histologic Hashimoto's thyroiditis.
Falk SA; Birken EA; Ronquillo AH
Otolaryngol Head Neck Surg; 1985 Feb; 93(1):86-91. PubMed ID: 3920630
[TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
18. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
19. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin.
Tellez M; Cooper J; Edmonds C
Clin Endocrinol (Oxf); 1992 Mar; 36(3):291-4. PubMed ID: 1563082
[TBL] [Abstract][Full Text] [Related]
20. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
De Bellis A; Bizzarro A; Gattoni A; Romano C; Di Martino S; Sinisi AA; Abbadessa S; Bellastella A
J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
